Exosens lifts mid-term growth targets as defence market booms
Published by Global Banking & Finance Review®
Posted on February 23, 2026
2 min readLast updated: February 23, 2026

Published by Global Banking & Finance Review®
Posted on February 23, 2026
2 min readLast updated: February 23, 2026

Exosens reported 22% revenue growth to €468.2m in 2025, while net profit from continuing operations doubled to €70.2m on booming defense demand. Defense was 75% of sales; guidance points to mid‑teens organic growth and stronger 2026.
Feb 23 (Reuters) - French defence technology group Exosens issued a higher medium-term guidance on Monday, after its net profit from continued operations more than doubled in 2025 driven by very strong demand in the defence and surveillance markets.
The company, which went public in June 2024, expects yearly organic revenue growth of 15%, versus a previous target for above mid-single-digit percentage growth. It also raised its organic growth target for earnings before interest, taxes, depreciation and amortisation (EBITDA) to more than 15% from high single-digits.
Military equipment orders have jumped after Russia's invasion of Ukraine in 2022 and Washington's more recent push for European allies to raise their defence spending.
"We saw a marked acceleration in requirements for defence imaging applications and, in particular, in surveillance, where fast-evolving drone threat landscape represents a major structural shift," Exosens CEO Jerome Cerisier said in a press release.
The maker of night-vision gear and components for scientific instruments reported a net profit of 70.2 million euros ($83.04 million) from continued operations for 2025, up from 34.1 million euros a year earlier, while revenue jumped 22% to 468.2 million euros.
Exosens, whose defence business makes up 75% of its revenue, proposed an annual dividend of 0.30 euros per share.
($1 = 0.8454 euros)
(Reporting by Hugo Lhomedet and Jakob Van Calster in Gdansk; Editing by Milla Nissi-Prussak)
Exosens reported strong 2025 results, with revenue up 22% to €468.2m and net profit from continuing operations more than doubling, driven by robust defense market demand.
A booming defense market lifted sales of night‑vision and related technologies, with defense representing 75% of group revenue.
Exosens expects a strong 2026 and targets mid‑teens organic revenue growth over the medium term, alongside improving profitability and free cash flow.
Explore more articles in the Finance category





